[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday
The stock price of Three Billion, an AI-based genetic disease diagnostic testing company, is showing a strong gain of over 20%.
As of 2:12 PM on the 17th, just before the market close, Three Billion's stock is trading at 6,970 KRW per share, up 22.93% compared to the previous trading day. During the session, the price briefly surpassed 7,000 KRW per share.
This surge is attributed to the news that the company signed a memorandum of understanding (MOU) for genetic testing cooperation with Korea AstraZeneca before the market opened, which triggered buying interest.
Hot Picks Today
"Betting with Advance Knowledge of Presidential Speeches"… Trump's Closest Aide Earns 150 Million Won
- Daegu Mayor Chu Kyung-ho Urges “Women-Owned Businesses, Making Up Over 40%, to Drive Daegu’s Economic Growth”
- Won Both 1st and 2nd Prizes With Birthday Lottery Ticket: "I Will Repay My Father Who Raised Us Alone"
- "Oops, No Condom... 'I Probably Won't Get Pregnant' – Alarming Neglect of Contraception Among Korean Adolescents"
- "Eerie Skies, Even Breathing Feels Scary"...Emergency Declared as Over 800 Wildfires Rage
Through this collaboration, Three Billion and AstraZeneca plan to establish a genetic testing system capable of completing diagnosis within two weeks for patients with atypical hemolytic uremic syndrome (aHUS), a rare disease.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.